Eiko Lifesciences (BOM:890189) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:890189 Eiko Lifesciences Ltd BOM:890189
70 GF Score
Price ₹22.90
GF Value ₹36.87
! 1 Warning Sign
View Full Analysis

What is Eiko Lifesciences Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Eiko Lifesciences is: No Data: Cannot be evaluated.

Eiko Lifesciences  (BOM:890189) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Eiko Lifesciences Risk Assessment Related Terms

BOM:890189 vs LIN, SHW, ECL: Risk Assessment Comparison

For the Specialty Chemicals subindustry, Eiko Lifesciences's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eiko Lifesciences Risk Assessment vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Eiko Lifesciences's Risk Assessment falls into.


BOM:890189
70GF Score
Eiko Lifesciences Ltd BOM:890189
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eiko Lifesciences (BOM:890189) Overvalued in 2026?

Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued. The current stock price of ₹22.90 is trading 37.9% below its estimated GF Value™ of ₹36.87.

Key valuation signals for BOM:890189:

  • Risk Assessment:
  • GF Value™: ₹36.87 vs. price of ₹22.90 (37.9% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the BOM:890189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eiko Lifesciences Business Description

Other Exchanges 540204:India
Address 604, Centrum, Wagle Estate, Opposite TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane, MH, IND, 400604
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
70GF Score

Get the complete analysis for BOM:890189

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹22.90
Price
₹36.87
GF Value